Monopar Therapeutics Inc. MNPR
Set alert
68.50 USD +2.22 +3.35%
As of Nov 3, 12:59 PM ET
66.29 Day range 68.79
50.07 52-week range 124.82
- YTD
- +4.90%
- 1 year
- -18.45%
- Open
- 66.75
- Prev close
- 66.28
- Mkt cap
- 459.11M
- Vol
- 68.32K
- Avg vol
- 167.44K
- EPS
- -2.20
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 66.29
- High
- 68.79
- Forward P/E
- -10.17
- Beta
- 1.10
- Short ratio
- 0.15
- Inst. own
- 24.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 9, 2024
- 50-d avg
- 17.85
- 200-d avg
- 7.12
- 1y target
- 27.33
5D chart
Signals (113)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| SMA: Bearish | Nov 2, 9:30 AM | 1 day ago |
| SMA: Bullish | Oct 30, 3:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 3:25 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:15 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 4 days ago |
| SMA: Bullish | Oct 30, 1:55 PM | 4 days ago |
| SMA: Bearish | Oct 30, 1:50 PM | 4 days ago |
| SMA: Bullish | Oct 30, 1:45 PM | 4 days ago |
| MACD: Sell Signal | Oct 30, 1:40 PM | 4 days ago |
| SMA: Bearish | Oct 30, 1:35 PM | 4 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 4 days ago |
| MACD: Buy Signal | Oct 30, 12:35 PM | 4 days ago |
| SMA: Bullish | Oct 30, 12:30 PM | 4 days ago |
| SMA: Bullish | Oct 30, 12:25 PM | 4 days ago |
| MACD: Sell Signal | Oct 30, 11:50 AM | 4 days ago |
Newest 20 of 113.
Financial health
Altman Z-Score
64.41 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 1
Valuation
P/E -35.3×
FY 2016 5y median -16.2× FY 2025
P/S 0.0×
FY 2016 5y median 0.0× FY 2025
P/B 3.5×
FY 2016 5y median 4.6× FY 2025
P/FCF -39.7×
FY 2016 5y median -27.4× FY 2025
EV/EBITDA -30.8×
FY 2016 5y median -13.6× FY 2025
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -2.5%
FY 2016 5y median -3.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2025
ROE -10.0%
FY 2016 5y median -48.1% FY 2025
ROIC -12.1%
FY 2016 5y median -48.2% FY 2025
ROA -9.7%
FY 2016 5y median -44.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -3.4%
FY 2016 FY 2025
EPS (diluted) -36.0%
FY 2016 FY 2025
Free Cash Flow -90.5%
FY 2016 FY 2025
Financial Health
Current Ratio 51.4×
FY 2016 5y median 11.5× FY 2025
Quick Ratio 51.4×
FY 2016 5y median 11.5× FY 2025
Debt / Equity 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 4.5×
FY 2016 5y median 2.2× FY 2025
Interest Coverage 0.0×
FY 2016 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
